Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on March 9, 2022. The report discloses a corporate governance event under Item 7.01 (Regulation FD Disclosure) regarding the adoption of a stock purchase plan by an executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive trading activity and does not contain financial performance data.
Material Changes
There are no material changes to financial operations or results reported in this document. The sole material event is the establishment of a Rule 10b5-1 trading plan by Michael Arends, Co-CEO.
Guidance, Outlook, and Management Commentary
- Executive Action: Michael Arends, Co-CEO, adopted a stock purchase plan with Merrill Lynch to purchase shares of Marchex's Class B common stock throughout 2022.
- Plan Details: The plan allows for purchases of specified share amounts at specific market prices, subject to limitations.
- Termination: The plan ends on the earlier of the purchase of the specified aggregate share amount or December 31, 2022.
- Compliance: The plan was adopted in accordance with the Marchex Code of Conduct and Rule 10b5-1, which permits prearranged trading when the officer is not in possession of material non-public information.
Investor Verification Checklist
- Verify the specific share amounts and price parameters of the Rule 10b5-1 plan in subsequent Form 4 filings.
- Confirm the execution of trades under this plan via future SEC filings.
- Note that this filing does not contain financial results; refer to the most recent 10-Q or 10-K for financial metrics.